Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>G Sachs Cuts DAMAI ENT (01060.HK) TP to $1.17, Keeps Buy Rating
Recommend 2 Positive 12 Negative 5 |
||||
|
||||
|
The stock price of DAMAI ENT (01060.HK) was relatively weak following the earnings release, Goldman Sachs said in its report. The broker attributed the stock price volatility to market concerns over the slowdown in DAMAI ENT's domestic ticketing business and increased international business investments. DAMAI ENT's high reliance on Japanese IP, amid Sino-Japanese tensions, impacted its IP merchandise business. However, Goldman Sachs considered DAMAI ENT's 1HFY26 results to be solid. As the company expands its licensing resources from Sanrio to retail and 2C markets, the strong licensing business will become the core growth driver in the next 6-12 months. The target price was reduced from HKD1.3 to HKD1.17, with the Buy rating maintained. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
